RSS

IPIX Innovation Pharmaceuticals Inc

Last Post: 10/20/26
Followers: 278
Posts Today: 0
Views Today: 11855

IPIX Stock Quote & Tools

$0.0006 ▲ +0.0001 (+20.00%) As of Oct 23, 1:15 PM EDT
Last0.0006
$ Chg0.0001
Open0.0006
High0.0006
Beta140.0971
Year High0.050
Market Cap311.0K
P/B Ratio0.09
EPS-0.01
Avg Vol (30d)159.3K
Volume1.08M
% Chg+20.00%
Prev Close0.0005
Low0.0005
VWAP0.00051
Year Low0.000
Total Shares518.35M
Shares Out514.01M
Float391.87M
ExchangeOTCID
Healthcare Biotechnology & Life Sciences

IPIX Stock Message Board Discussion

  1. Commando911
  2. scgmck1
  3. scgmck1
  4. Drano

Top 10 Most Recent News Articles

Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 130

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 117

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 201

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 65

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 215

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 152

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 119

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

R. Scot Buell: From Oil Fields to Inner Excellence

Updated Category News Views 14

R. Scot Buell: A Catalyst in Petroleum Engineering So, here's the skinny on R. Scot Buell, a guy whose name rings bells in the petroleum engineering corridors. The Inner Circle's tip of the hat to him as a Pinnacle Professional Member Inner Circle of Excellence isn't just a ceremonial bash—it stamps on a career that has gone all out in the energy sector. What's this...

Continue Reading
Forbes Honors Check Point Software as Premier Cybersecurity Employer

Updated Category News Views 133

Check Point Software Achieves Remarkable Recognition Check Point Software Technologies Ltd. (NASDAQ: CHKP) has recently earned a prestigious accolade from Forbes, being named one of the World’s Best Employers for the fifth consecutive year. This recognition highlights the company's commitment not just to cybersecurity, but to creating an inspiring workplace for its...

Continue Reading
Coinbase CEO Predicts Bitcoin Will Reach $18 Trillion Market Value

Updated Category News Views 154

Bitcoin's Remarkable Ascent Towards $18 Trillion U.Today reports that Bitcoin (BTC) is increasingly seen as a superior monetary asset compared to traditional reserves like gold. The CEO of Coinbase (NASDAQ: COIN) emphasizes that Bitcoin has unique advantages that may lead it to achieve a staggering market valuation of over $18 trillion. Currently, Bitcoin's market value...

Continue Reading
Certara Unveils Innovative Non-Animal Testing Solution for Drug Developers

Updated Category News Views 127

Introducing Certara's Groundbreaking Non-Animal Navigator Solution In an exciting development for the pharmaceutical industry, Certara, Inc. (Nasdaq: CERT), a leading force in model-informed drug development, has launched its innovative Non-Animal Navigator solution. This new initiative is designed to help biopharmaceutical companies transition towards reduced reliance on...

Continue Reading
Dr. Gerard van Belle Takes Helm as Director of Science

Updated Category News Views 394

Dr. Gerard van Belle Appointed Director of Science at Lowell Observatory Dr. Gerard van Belle has officially taken the role of Director of Science at Lowell Observatory, managing a team tasked with groundbreaking astronomical exploration and innovation. Leading a New Era in Astronomy In this pivotal position, van Belle is set to guide a diverse group of astronomers and...

Continue Reading